Modulating Cell Fate as a Therapeutic Strategy.

Autor:	Lin B; Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA., Srikanth P; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Pathways Program, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Castle AC; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Pathways Program, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Nigwekar S; Pathways Program, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Malhotra R; Pathways Program, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, USA., Galloway JL; Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA., Sykes DB; Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA., Rajagopal J; Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Pathways Program, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Pediatric Pulmonary Medicine, Massachusetts General Hospital for Children, Boston, MA 02114, USA. Electronic address: jrajagopal@mgh.harvard.edu.
Jazyk:	angličtina
Zdroj:	Cell stem cell [Cell Stem Cell] 2018 Sep 06; Vol. 23 (3), pp. 329-341. Date of Electronic Publication: 2018 Jun 14.
DOI:	10.1016/j.stem.2018.05.009
Abstrakt:	In injured tissues, regeneration is often associated with cell fate plasticity, in that cells deviate from their normal lineage paths. It is becoming increasingly clear that this plasticity often creates alternative strategies to restore damaged or lost cells. Alternatively, cell fate plasticity is also part and parcel of pathologic tissue transformations that accompany disease. In this Perspective, we summarize a few illustrative examples of physiologic and aberrant cellular plasticity. Then, we speculate on how one could enhance endogenous plasticity to promote regeneration and reverse pathologic plasticity, perhaps inspiring interest in a new class of therapies targeting cell fate modulation. (Copyright © 2018 Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu